Current methods used for the release testing of CAR-T cell therapies significantly impact their cost and turnaround times, ultimately affecting patient access. Resilience is now offering a modernized and powerful tool to add to your characterization toolbox with accurate and reliable data without compromising quality generated by a state-of-the-art assay.
Gain a comprehensive view of your CAR-T cell therapy with Kona Multiomics Characterization Assay Services. Our innovative approach provides cell surface protein detection and gene expression data from the same cells. Leverage our expert scientific team to empower you with the deep insights needed to optimize your drug product. Download the Fact Sheet below to see the data.
Why Multiomics Profiling? Accessing a complete view of protein and gene expression from the same cells in your CAR-T product can enable the correlation of phenotypes with functional outcomes and can identify critical quality attributes (CQAs) to link with clinical outcomes. Increasing our level of understanding can contribute to better therapeutic potential and ultimately, patient outcomes.
Benefits of Kona Characterization Assay Services:
- High-Resolution Insights: Profile heterogeneous cell populations with precision
- Efficiency: Minimize sample use while extracting deeper data (RNA & protein) from the same cells
- Phenotypic Profiling: Characterize cellular phenotypes and functional states in detail
- Clinical Impact: Correlate phenotypes with functional outcomes for better therapies
- Experience: Work is completed by our highly skilled team inside our 85,000 sq. ft. Center of Excellence for Cellular Immunotherapy located in Philadelphia, PA
Interested in speaking with a team member about accessing Kona Multiomics Characterization Assay? Kona is available as a standalone assay service or as part of our cell therapy manufacturing packages.
Connect with us here to discuss which option is best suited to your needs
